Literature DB >> 10721049

Kynurenine pathway metabolism in human astrocytes.

G J Guillemin1, S J Kerr, G A Smythe, P J Armati, B J Brew.   

Abstract

The involvement of astrocytes in Kynurenine pathway (KP) metabolism is still poorly understood. In the present study, we investigated the ability of human fetal astrocytes in vitro to produce quinolinic and picolinic acids using mass spectrometry. In parallel, we estimated the level of expression of five major KP enzymes using RT-PCR. The results demonstrated that astrocytes express most KP enzymes, except for kynurenine-hydroxylase. This in vitro study provides novel informations regarding the ability of human fetal astrocytes to degrade L-tryptophan along the KP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10721049     DOI: 10.1007/978-1-4615-4709-9_18

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  12 in total

Review 1.  Disease-modifying pathways in neurodegeneration.

Authors:  Steven Finkbeiner; Ana Maria Cuervo; Richard I Morimoto; Paul J Muchowski
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

2.  Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat.

Authors:  D G Smith; G J Guillemin; L Pemberton; S Kerr; A Nath; G A Smythe; B J Brew
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

3.  Tryptophan catabolism: identification and characterization of a new degradative pathway.

Authors:  Keri L Colabroy; Tadhg P Begley
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

4.  Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia.

Authors:  Ikwunga Wonodi; Robert P McMahon; Nithin Krishna; Braxton D Mitchell; Judy Liu; Matthew Glassman; L Elliot Hong; James M Gold
Journal:  Schizophr Res       Date:  2014-11-14       Impact factor: 4.939

5.  Astrocytic amino acid metabolism under control conditions and during oxygen and/or glucose deprivation.

Authors:  Leif Hertz
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

6.  Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease.

Authors:  David J Bonda; Maneesh Mailankot; Jeremy G Stone; Matthew R Garrett; Magdalena Staniszewska; Rudy J Castellani; Sandra L Siedlak; Xiongwei Zhu; Hyoung-gon Lee; George Perry; Ram H Nagaraj; Mark A Smith
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

Review 7.  The involvement of astrocytes and kynurenine pathway in Alzheimer's disease.

Authors:  Ka Ka Ting; Bruce Brew; Gilles Guillemin
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

8.  On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo.

Authors:  Laura Amori; Paolo Guidetti; Roberto Pellicciari; Yasushi Kajii; Robert Schwarcz
Journal:  J Neurochem       Date:  2009-02-06       Impact factor: 5.372

9.  Characterization of the Kynurenine Pathway in CD8+ Human Primary Monocyte-Derived Dendritic Cells.

Authors:  Nady Braidy; Helene Rossez; Chai K Lim; Bat-Erdene Jugder; Bruce J Brew; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2016-08-10       Impact factor: 3.911

Review 10.  Kynurenines, neurodegeneration and Alzheimer's disease.

Authors:  Zsigmond Tamas Kincses; József Toldi; László Vécsei
Journal:  J Cell Mol Med       Date:  2010-07-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.